Up a level |
(2021) Development of a chimeric vaccine candidate based on Toxoplasma gondii major surface antigen 1 and apicoplast proteins using comprehensive immunoinformatics approaches. European Journal of Pharmaceutical Sciences. p. 12. ISSN 0928-0987